Cargando…

A theory on ICER pricing and optimal levels of cost-effectiveness thresholds: a bargaining approach

In many health systems around the world, decisions about the reimbursement of—and patient access to—new medicines are based on health technology assessments (HTA) which, in some countries, include the calculation of an incremental cost-effectiveness ratio (ICER). Decision-makers compare the ICER aga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berdud, Mikel, Ferraro, Jimena, Towse, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Health Services
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484610/ https://www.ncbi.nlm.nih.gov/pubmed/37693236 http://dx.doi.org/10.3389/frhs.2023.1055471

Ejemplares similares

The cost-per-QALY threshold in England: Identifying structural uncertainty in the estimates
por: Zamora, Bernarda, et al.
Publicado: (2023)

Establishing a reasonable price for an orphan drug
por: Berdud, Mikel, et al.
Publicado: (2020)

Editorial: Opportunity costs in health care: cost-effectiveness thresholds and beyond
por: Sampson, Chris, et al.
Publicado: (2023)

Biosimilars: How Can Payers Get Long-Term Savings?
por: Mestre-Ferrandiz, Jorge, et al.
Publicado: (2016)

ICER update to pricing models of remdesivir for COVID-19
Publicado: (2020)

ICER releases pricing models for potential COVID-19 treatments
Publicado: (2020)

ICER's second update to pricing models of remdesivir for COVID-19
Publicado: (2020)

Bilateral bargaining: theory and applications
por: Fandel, G, et al.
Publicado: (1986)

Options for states to constrain pricing power of health care providers
por: Gudiksen, Katherine L., et al.
Publicado: (2022)

Should Drug Companies Engage with ICER? An Empirical Analysis of How Often Manufacturers Engage with ICER and Whether Engagement May Influence ICER’s Cost-Effectiveness Estimates
por: Breslau, Rachel Milstein, et al.
Publicado: (2022)

Decision Thresholds for Medical Tests Under Ambiguity Aversion
por: Sevim, Dilek, et al.
Publicado: (2022)

Worldwide HTA access to ICER's cost-effectiveness models
Publicado: (2020)

Physician Collective Bargaining
por: Schiff, Anthony Hunter
Publicado: (2009)

How reliable are ICER’s results published in current pharmacoeconomic literature? The controversial issue of price confidentiality
por: Russo, Pierluigi
Publicado: (2022)

Alternating-Offers Bargaining with Nash Bargaining Fairness Concerns
por: Feng, Zhongwei, et al.
Publicado: (2023)

Smashing bargain
Publicado: (1994)

Evidence for tuning adipocytes ICER levels for obesity care
por: Brajkovic, Saška, et al.
Publicado: (2012)

Business–nonprofit hybrid organizing: a dynamic approach to balancing benefits and costs
por: Aveling, Emma-Louise, et al.
Publicado: (2023)

Virtual bargaining: a theory of social decision-making
por: Misyak, Jennifer B., et al.
Publicado: (2014)

Increasing Access to Organization Theories for Implementation Science
por: Birken, Sarah A., et al.
Publicado: (2022)

Editorial: The theory and pragmatics of power and relationships in implementation
por: Finley, Erin P., et al.
Publicado: (2023)

A Faustian bargain
por: Petsko, Gregory A
Publicado: (2010)

Intertemporal Bargaining in Addiction
por: Ainslie, George
Publicado: (2013)

Bargaining for the Supply of Medicines
Publicado: (1905)

Language effects on bargaining
por: Weir, Michael J., et al.
Publicado: (2020)

Dynamic Bargain Game Theory in the Internet of Things for Data Trustworthiness
por: Sumathi, Appasamy C., et al.
Publicado: (2021)

Editorial: Advancements and challenges in cost and resource allocation: 2022
por: Hafidz, Firdaus, et al.
Publicado: (2023)

To bargain or not to bargain: Airlines, legitimacy and nonmarket strategy in a COVID-19 world
por: Akbar, Yusaf H., et al.
Publicado: (2020)

ICER is requisite for Th17 differentiation
por: Yoshida, Nobuya, et al.
Publicado: (2016)

The ICER review is in: hope amidst uncertainty
por: Begolka, Wendy Smith, et al.
Publicado: (2022)

Counting the costs of accreditation in acute care: an activity-based costing approach
por: Mumford, Virginia, et al.
Publicado: (2015)

A Monte Carlo Simulation Approach to Optimizing Capacity in a High-Volume Congenital Heart Pediatric Surgical Center
por: Elia, Eleni G., et al.
Publicado: (2022)

Recycling Pricing and Coordination of WEEE Dual-Channel Closed-Loop Supply Chain Considering Consumers’ Bargaining
por: Zhu, Xiaodong, et al.
Publicado: (2017)

The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson’s disease
por: Jørgensen, Jesper, et al.
Publicado: (2018)

The ethics of aggregation in cost-effectiveness analysis or, “on books, bookshelves, and budget impact”
por: Charlton, Victoria
Publicado: (2022)

Analysis of variation in charges and prices paid for vaginal and caesarean section births: a cross-sectional study
por: Hsia, Renee Y, et al.
Publicado: (2014)

The evolution of ICER’s review process for new medical interventions and a critical review of economic evaluations (2018-2019): how stakeholders can collaborate with ICER to improve the quality of evidence in ICER’s reports
por: Ronquest, Naoko A, et al.
Publicado: (2021)

What implementation strategies are relational? Using Relational Theory to explore the ERIC implementation strategies
por: Bartley, Leah, et al.
Publicado: (2022)

Applying Theory to Explain the Influence of Factors External to an Organization on the Implementation of an Evidence-Based Intervention
por: Leeman, Jennifer, et al.
Publicado: (2022)

Pricing Services: An Underutilized Policy Instrument for Access and Quality
por: Barber, Sarah L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rapilfphlj1qp54r6j0950pjut